Amgen (AMGN) Fair Value & DCF
Score
AMGN fair value $624.46. Price $465.67. Price is 25% below fair value.
Worked example
Cash-flow value. Starting free cash flow is $17.71 a share. Year 1 is the first earnings forecast, so it has no growth rate of its own. The forecast then reaches 7.32%, and that pace fades in a straight line to 3% terminal growth by year 10. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $550.68 a share.
Earnings value. Next-twelve-months earnings per share of $24.33 times 28.70 is $698.24. The peer group is Drug Manufacturers - General, 8 companies worth at least $10 billion. Peer median 35.7. Own 10-year median 21.7. The multiple used is the average of the two, kept between 8 and 30, which is 28.70.
Fair value is the average of the two, $624.46. The price is $465.67, which is 25.4% below fair value.